Sidney C. Smith
- Acute Myocardial Infarction Research
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Imaging and Diagnostics
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Health and Mental Health
- Heart Failure Treatment and Management
- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Coronary Interventions and Diagnostics
- Global Public Health Policies and Epidemiology
- Cardiac Arrest and Resuscitation
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Clinical practice guidelines implementation
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Health and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Healthcare Policy and Management
- Cardiac Valve Diseases and Treatments
- Peripheral Artery Disease Management
- Cardiac Structural Anomalies and Repair
University of North Carolina at Chapel Hill
2016-2025
Smith Family
2002-2024
University of North Carolina Wilmington
2024
Ten Chen Hospital
2024
Instituto Nacional de Cardiologia
2023
Capital Medical University
2009-2022
Georgetown University
1995-2022
Beijing Anzhen Hospital
2017-2022
MedStar Georgetown University Hospital
2022
Palo Alto Institute
2019-2021
A cluster of risk factors for cardiovascular disease and type 2 diabetes mellitus, which occur together more often than by chance alone, have become known as the metabolic syndrome. The include raised blood pressure, dyslipidemia (raised triglycerides lowered high-density lipoprotein cholesterol), fasting glucose, central obesity. Various diagnostic criteria been proposed different organizations over past decade. Most recently, these come from International Diabetes Federation American Heart...
In 1998, the American Heart Association convened Prevention Conference V to examine strategies for identification of high-risk patients who need primary prevention. Among discussed was measurement markers inflammation.1 The concluded that “many these (including inflammatory markers) are not yet considered applicable routine risk assessment because of: (1) lack standardization, (2) consistency in epidemiological findings from prospective studies with endpoints, and (3) evidence novel marker...
Kristian Thygesen∗ (Denmark) Joseph S. Alpert∗ (USA) Allan Jaffe (USA) Bernard R. Chaitman (USA) Jeroen J. Bax (The Netherlands) David A. Morrow (USA) Harvey D. White∗ (New Zealand) Hans Mickley (Denmark) Filippo Crea (Italy) Frans Van de Werf (Belgium) Chiara Bucciarelli-Ducci (
HomeCirculationVol. 102, No. 10ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary Recommendations
HomeCirculationVol. 113, No. 19AHA/ACC Guidelines for Secondary Prevention Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result an outside relationship
Grundy, Scott M. MD, PhD, Chair; Cleeman, James I. Co-Chair; Daniels, Stephen R. PhD; Donato, Karen A. MS, RD; Eckel, Robert H. MD; Franklin, Barry Gordon, David J. MD MPH; Krauss, Ronald Savage, Peter Smith, Sidney C. Jr Spertus, John Costa, Fernando Author Information